Theravance生物制药

TBPH NASDAQ
15.95
-0.81
-4.83%
已收盘, 16:34 06/14 EDT
开盘
16.67
昨收
16.76
最高
17.15
最低
15.70
成交量
40.02万
成交均量(3M)
27.59万
52周最高
35.48
52周最低
15.18
换手率
0.71%
市值
8.95亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Theravance生物制药 TBPH股票价格,Theravance生物制药股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Theravance Biopharma, Inc. is a biopharmaceutical company. The Company is engaged in creating medicines for patients suffering from serious illness. The Company operates in the segment of discovery (research), development and commercialization of human therapeutics. The Company's pipeline of internally discovered product candidates includes medicines to address the unmet needs of patients being treated for serious conditions primarily in the acute care setting. Its commercial product VIBATIV (telavancin) is a once-daily dual-mechanism antibiotic approved in the United States and Europe for certain difficult-to-treat infections. Its Revefenacin (TD-4208) is a long-acting muscarinic antagonist (LAMA) being developed as a nebulized treatment for chronic obstructive pulmonary disease. Its neprilysin (NEP) inhibitor program is designed to develop selective NEP inhibitors for the treatment of a range of cardiovascular and renal diseases.
展开 >

最近浏览

名称
价格
涨跌幅